Home>News> J&J scores as judge cuts $8 billion Risperdal verdict to just $6.8 million

J&J scores as judge cuts $8 billion Risperdal verdict to just $6.8 million

Johnson & Johnson last fall suffered a major legal defeat in its defense of antipsychotic Risperdal, but that loss was short-lived. After a jury ordered J&J to pay a plaintiff a staggering $8 billion, the trial judge has dramatically cut the verdict.
 
The $8 billion punitive damages award was reduced to $6.8 million in the case of Nicholas Murray, according to court documents. Murray sued J&J in 2013 alleging his off-label use of Risperdal caused him to develop breasts, and a jury sided with the plaintiff in October.

Tags: